Drug Type Small molecule drug |
Synonyms DNDI-8219 |
Target |
Mechanism hERG blockers(Voltage-gated potassium channel subunit Kv11.1 blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC13H10F3N3O5 |
InChIKeyIXUWKDINJWESQG-SNVBAGLBSA-N |
CAS Registry2222660-40-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leishmaniasis, Visceral | Preclinical | NZ | 22 Mar 2018 |